Complete and durable response of pulmonary large‐cell neuroendocrine carcinoma to pembrolizumab

BACKGROUND: Pulmonary large cell neuroendocrine carcinoma (LCNEC) is a rare and aggressive tumor with a poor prognosis and standard therapy has not yet been established. CASE: A 65‐year‐old male with a cough for 2 months presented to our hospital. He was clinically diagnosed with non small cell lung...

Descripción completa

Detalles Bibliográficos
Autores principales: Kadota, Naoki, Hatakeyama, Nobuo, Hino, Hiroyuki, Kunishige, Michihiro, Kondo, Yoshihiro, Okano, Yoshio, Machida, Hisanori, Naruse, Keishi, Shinohara, Tsutomu, Sakiyama, Shoji, Ogushi, Fumitaka, Takeuchi, Eiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351647/
https://www.ncbi.nlm.nih.gov/pubmed/34817132
http://dx.doi.org/10.1002/cnr2.1589

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351647/
https://www.ncbi.nlm.nih.gov/pubmed/34817132
http://dx.doi.org/10.1002/cnr2.1589

Ejemplares similares